MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction

Podobne knjige/članki

• Preclinical to clinical translation of anti-PD-1 blockade
  od: Hirsch, Heather, et al.
  Izdano: (2015)
• Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade
  od: Mueller, Antonia MS, et al.
  Izdano: (2014)
• Radiotherapy induces responsiveness of a resistant mammary carcinoma to PD-1 blockade
  od: Diamond, Julie, et al.
  Izdano: (2014)
• Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
  od: Wu, Si-Pei, et al.
  Izdano: (2015)
• The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
  od: Andrews, Lawrence P, et al.
  Izdano: (2015)